Prokidney (PROK) Operating Expenses (2021 - 2026)

Prokidney (PROK) has 6 years of Operating Expenses data on file, last reported at $45.2 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 8.51% year-over-year to $45.2 million in Q1 2026; TTM through Mar 2026 was $169.4 million, a 8.56% decrease from a year earlier, with the FY2025 full-year figure at $165.9 million, down 9.72% from the prior year.
• Operating Expenses for Q1 2026 stood at $45.2 million, down from $45.6 million in the prior quarter.
• Over the last five years, Operating Expenses for PROK reached as high as $66.5 million in Q1 2022 and fell as low as $20.7 million in Q2 2022.
• Historically, Operating Expenses has averaged $41.1 million across 5 years, with a median of $40.9 million in 2023.
• Across the five-year window, Operating Expenses jumped 14501997.9% in 2022 and sank 38.5% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $30.2 million in 2022, then decreased by 19.93% to $24.2 million in 2023, then jumped by 113.33% to $51.6 million in 2024, then declined by 11.72% to $45.6 million in 2025, then decreased by 0.96% to $45.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $45.2 million in Q1 2026, $45.6 million in Q4 2025, and $38.8 million in Q3 2025.